Dr Reddy's launches allergy relief tablets in US

Drug firm Dr Reddy's Laboratories has launched levocetirizine dihydrochloride tablets, used for relieving allergies, in the US market.

In a BSE filing, Dr Reddy's Laboratories said it had "launched levocetirizine dihydrochloride tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of UCB's Xyzal allergy tablets, in the US market as approved by the US Food and Drug Administration (USFDA)."